fresolimumab
cancer | fresolimumab |
As nouns the difference between cancer and fresolimumab is that cancer is cancer while fresolimumab is a human monoclonal antibody and immunomodulator under investigation for the treatment of idiopathic pulmonary fibrosis, focal segmental glomerulosclerosis, and cancer.
glomerulosclerosis | fresolimumab |
As nouns the difference between glomerulosclerosis and fresolimumab is that glomerulosclerosis is (medicine) a hardening of the glomerulus in the kidney while fresolimumab is a human monoclonal antibody and immunomodulator under investigation for the treatment of idiopathic pulmonary fibrosis, focal segmental glomerulosclerosis, and cancer.
segmental | fresolimumab |
As an adjective segmental is of, relating to, or constructed from segments. As a noun fresolimumab is a human monoclonal antibody and immunomodulator under investigation for the treatment of idiopathic pulmonary fibrosis, focal segmental glomerulosclerosis, and cancer.
focal | fresolimumab |
As an adjective focal is belonging to, concerning, or located at a focus. As a noun fresolimumab is a human monoclonal antibody and immunomodulator under investigation for the treatment of idiopathic pulmonary fibrosis, focal segmental glomerulosclerosis, and cancer.
fibrosis | fresolimumab |
As nouns the difference between fibrosis and fresolimumab is that fibrosis is (medicine) the formation of excess fibrous connective tissue in an organ while fresolimumab is a human monoclonal antibody and immunomodulator under investigation for the treatment of idiopathic pulmonary fibrosis, focal segmental glomerulosclerosis, and cancer.
pulmonary | fresolimumab |
As an adjective pulmonary is pertaining to, having, or affecting the lungs. As a noun fresolimumab is a human monoclonal antibody and immunomodulator under investigation for the treatment of idiopathic pulmonary fibrosis, focal segmental glomerulosclerosis, and cancer.
idiopathic | fresolimumab |
As an adjective idiopathic is (pathology) of, relating to, or designating a disease or condition having no known cause. As a noun fresolimumab is a human monoclonal antibody and immunomodulator under investigation for the treatment of idiopathic pulmonary fibrosis, focal segmental glomerulosclerosis, and cancer.
immunomodulator | fresolimumab |
As nouns the difference between immunomodulator and fresolimumab is that immunomodulator is a drug used for its effect on the immune system while fresolimumab is a human monoclonal antibody and immunomodulator under investigation for the treatment of idiopathic pulmonary fibrosis, focal segmental glomerulosclerosis, and cancer.
human | fresolimumab |
As an adjective human is ( label) classical (of or pertaining to the classical - latin, greek - languages, literature, history and philosophy). As a noun fresolimumab is a human monoclonal antibody and immunomodulator under investigation for the treatment of idiopathic pulmonary fibrosis, focal segmental glomerulosclerosis, and cancer.
|
